What is HSCS's relative strength rating?

HSCS ranks at the 79th percentile over 1 month, 91th percentile over 3 months, 40th percentile over 6 months, 27th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is HSCS in?

HSCS is classified under the Healthcare sector within the Medical Equipment industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is HSCS in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). HSCS benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is HSCS?

HSCS currently shows a 20-day average daily range (ADR%) of 12.2%, a 90-day beta versus the S&P 500 of -1.66. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does HSCS have a seasonal pattern?

TickerStance computes HSCS's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what HSCS has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did HSCS last report earnings?

HSCS most recently filed a 10-K covering FY25 Q2 with the SEC on 2026-07-23. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

HeartSciences Inc. Common Stock (HSCS) · RS 40

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, HeartSciences Inc. Common Stock (HSCS) has a 3-month relative strength percentile of 91 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 51. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 12.2%, relative volume 7.97×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month91pctile

6 month40pctile

1 year27pctile

Classic53IBD pctile

LDR29leadership

0 of 5 lenses lit · avg RS pctile 48

✓ADR%12.2%✓A/DA✓RVOL7.97×!$ Vol$8M

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

10y · since 2022

Best monthJan on averageavg +32.86% · 50% win · n 4

Worst monthNov on averageavg -16.20% · 25% win · n 4

HSCS monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	HSCS Jan avg: 32.86% median: -3.93% win: 50% σ: 81.77% n: 4 2022-06-16 → 2026-07-31	HSCS Feb avg: -15.28% median: -17.49% win: 25% σ: 19.49% n: 4 2022-06-16 → 2026-07-31	HSCS Mar avg: -14.73% median: -15.28% win: 0% σ: 11.73% n: 4 2022-06-16 → 2026-07-31	HSCS Apr avg: -7.30% median: -15.52% win: 25% σ: 21.77% n: 4 2022-06-16 → 2026-07-31	HSCS May avg: -10.35% median: -6.80% win: 50% σ: 22.93% n: 4 2022-06-16 → 2026-07-31	HSCS Jun avg: 10.39% median: 6.17% win: 60% σ: 23.72% n: 5 2022-06-16 → 2026-07-31	HSCS Jul avg: -15.92% median: -16.80% win: 0% σ: 8.37% n: 5 2022-06-16 → 2026-07-31	HSCS Aug avg: -6.21% median: -7.18% win: 25% σ: 12.47% n: 4 2022-06-16 → 2026-07-31 (current)	HSCS Sep avg: -3.40% median: -8.56% win: 50% σ: 35.01% n: 4 2022-06-16 → 2026-07-31	HSCS Oct avg: 3.49% median: -25.87% win: 25% σ: 70.40% n: 4 2022-06-16 → 2026-07-31	HSCS Nov avg: -16.20% median: -7.51% win: 25% σ: 23.21% n: 4 2022-06-16 → 2026-07-31	HSCS Dec avg: -3.93% median: -7.02% win: 50% σ: 30.95% n: 4 2022-06-16 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

2 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

79

3m

91

6m

40

1y

27

LDR

—

StageWeinstein stage analysis

Stage 1 · Basing

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · HSCS

Does the business back the chart?

SEC EDGAR · last filing 10-K · FY25 Q2 · period end 2025-10-31

18

Fundamentals Growth Rank

How does growth rank vs. the universe?

vs. 4,480 ranked stocks · Sector rank 22

View fundamental leadership map

Laggard

Earnings

Are losses narrowing?

Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.

Loss narrowing

−$0.03—

24 Q1

−$14.06—

24 Q4

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
HSCS
91RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Medical Equipment

Same industry, closest relative strength

4 peers · by RS6M

NPCENeuropace, Inc. Common Stock41 ESTAEstablishment Labs Holdings Inc.41 PENPenumbra, Inc.40 STESTERIS plc41

Public attention · HSCS

Is the crowd watching?

45/ 100 · vs its own 90-day norm▲ 17 vs 7dStealth leader

Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryMedical Equipment

SIC3842

Float2.8Mshares

Shares out3.9Mshares

Market cap$10.8MNano Cap

FAQ

Frequently asked questions

What is HSCS's relative strength rating?: HSCS ranks at the 79th percentile over 1 month, 91th percentile over 3 months, 40th percentile over 6 months, 27th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is HSCS in?: HSCS is classified under the Healthcare sector within the Medical Equipment industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is HSCS in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). HSCS benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is HSCS?: HSCS currently shows a 20-day average daily range (ADR%) of 12.2%, a 90-day beta versus the S&P 500 of -1.66. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does HSCS have a seasonal pattern?: TickerStance computes HSCS's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what HSCS has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

HeartSciences Inc. Common Stock (HSCS) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Are losses narrowing?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

§ Seasonality

HeartSciences Inc. Common Stock (HSCS) — Stance & relative strength

HSCS is on the watchlist, not confirmed. 3m RS is 91, Market Stance is mixed at 47.8, A/D rating A

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Are losses narrowing?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?